Rare diseases
Investigational molecules
Locations
Back to Estonia23 clinical trials in Pohja-Tallinna Linnaosa, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
EstoniaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
EstoniaLong‑Term Follow‑Up of Mitomycin (UGN‑103) Treatment in Patients with Recurrent Low‑Grade Intermediate‑Risk Non‑Muscle Invasive Bladder Cancer
EstoniaStudy on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia
EstoniaEstoniaStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
EstoniaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
EstoniaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
EstoniaStudy on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
EstoniaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
EstoniaStudy on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
EstoniaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
EstoniaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on evaluating treatments for multiple sclerosis, including long-term safety studies of medications like ocrelizumab and ofatumumab for patients with relapsing forms of MS.
Comprehensive studies investigating innovative therapies for inflammatory bowel diseases, including trials for both Crohn's Disease and Ulcerative Colitis using novel combination treatments.
Studies evaluating new treatments for stroke prevention and management of atrial fibrillation, including trials of novel anticoagulants and therapeutic approaches.
Clinical investigations focusing on bladder cancer treatments and complicated urinary tract infections, evaluating new therapeutic approaches and medication combinations.
Innovative studies examining treatments for various kidney conditions, including IgA Nephropathy and focal segmental glomerulosclerosis, with focus on long-term outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
